First Tracks Biotherapeutics, Inc. (TRAX)
NASDAQ: TRAX · Real-Time Price · USD
17.71
-4.80 (-21.32%)
Apr 20, 2026, 12:41 PM EDT - Market open
Company Description
First Tracks Biotherapeutics, Inc. operates as a clinical-stage biotechnology company developing antibody therapeutics that modulate immune pathways implicated in autoimmune and inflammatory diseases.
First Tracks Biotherapeutics, Inc. was incorporated in 2025 and is headquartered in San Diego, California.
First Tracks Biotherapeutics, Inc. operates as a subsidiary of AnaptysBio, Inc.
First Tracks Biotherapeutics, Inc.
| Country | United States |
| Founded | 2025 |
| CEO | Daniel Faga |
Contact Details
Address: 10770 Wateridge Circle, Suite 210 San Diego, California 92121 United States |
Stock Details
| Ticker Symbol | TRAX |
| Exchange | NASDAQ |
| Stock Type | Common Stock |
| Reporting Currency | USD |
Key Executives
| Name | Position |
|---|---|
| Daniel Faga | Chief Executive Officer |
| Dennis Mulroy | Chief Financial Officer |